1359-6446/01/$ – see front matter ©2001 Elsevier Science Ltd. All rights reserved. PII: S1359-6446(01)02070-0
▼ The field of combinatorial chemistry hasreceived a great deal of interest for the rapidgeneration of novel and drug-like heterocyclicscaffolds. Today, chemists face increasinglyhigh demands for novel compound librarieswith drug-like properties for screening against a rapidly growing range of therapeutictargets resulting from genomics research.Combinatorial libraries, depending on theirutility, can be categorized into several classes,including broad and diverse discovery libraries,targeted libraries and focused libraries.Therefore, the strategies for design and synthesis of these libraries are implementedin different ways1. However, the followingchallenges and problems in generating asmall-molecule combinatorial library are al-ways encountered regardless of whether it is amixture- or single-compound-based library:• Solid-phase vs solution-phase synthesis;• Drug-like properties;• Novelty and patentability;• Molecular diversity;• Efficiency of synthesis;
• Purity of compound libraries;• Cost of production; and• Compatibility with automation.
Although there has been a rapid growth ofliterature dealing with the development ofnovel strategies for addressing these issues,the scope of this article is limited. Thus, thisreview can only highlight the recent and rep-resentative examples with a combination ofthe author’s own work and current interests,primarily focused on novel synthetic strategiesfor rapidly generating heterocyclic scaffoldsand combinatorial libraries on a solid support.The strategies relating to the development ofnovel linkers for solid-phase synthesis2, high-throughput purification of combinatorial libraries3 and rational approaches in librarydesign4 are not reviewed here.
Template-based approachThe concept of ‘privileged structures’ was introduced by Evans and coworkers in 1988(Ref. 5), and recently updated by Patchett6. Aprivileged structure is ‘a single molecularframework able to provide ligands for diversereceptors’. A classic example of privileged struc-ture is the benzodiazepine moiety that is foundin a variety of therapeutic agents. To exploitmolecular diversity and generate drug-likecombinatorial libraries for various biologicaltargets, these privileged structures have beenused as templates from which functional varia-tions can be achieved at multiple diversificationpositions using combinatorial approaches.These libraries are used for screening in a vari-ety of biological assays and exploring theirability to affect particular pathways in cells ororganisms, hopefully leading to the discoveryof highly specific and effective molecules.
Novel strategies for solid-phaseconstruction of small-moleculecombinatorial librariesBoliang Lou
Boliang LouAdvanced SynTech
9800 Bluegrass ParkwayLouisville
KT 40299, USAtel: +1 502 499 0122fax: +1 502 499 0078
e-mail: [email protected]
During the past decade we witnessed a rapid advance in the new field
of chemical science, combinatorial chemistry. The pharmaceutical industries
invested heavily in accelerating the development of this new technology.
As a result, it has become an extremely important tool in lead
identification and optimization in current pharmaceutical research. It
also quickly crossed the boundaries of the original chemical discipline
and demonstrated great potential in many other important areas, such
as searching for novel and highly efficient catalysts and superconductive
material. Researchers from both academic and industrial laboratories have
directed great effort towards the development of novel strategies for
combinatorial synthesis.
1288
DDT Vol. 6, No. 24 December 2001reviews research focus
www.drugdiscoverytoday.com
reviewsresearch focus
1289
DDT Vol. 6, No. 24 December 2001
www.drugdiscoverytoday.com
The purine structure can be found in many agonists, antagonists and sub-strates7,8, and it plays a crucial role inmany cellular processes. Therefore, theexploration of chemical diversity basedon the purine template and the devel-opment of practical synthetic proto-cols was an attractive objective; thereare several approaches reported in theliterature (Fig. 1)9–16. The most impres-sive was the solid- and solution-phasecombination strategy developed bySchultz and coworkers9,10,12,14, whichenables the complete diversification atthe C2, C6 and N9 positions on thepurine template. From the libraries,the same group then identified a seriesof highly potent and selective CDK2-kinase inhibitors. The most potent inhibitor has an IC50 value againstCDK2-cyclin A of 6 nM (Ref. 9).
The common features in both thesolid- and solution-phase synthesesshown in Fig. 19–15 are the Mitsunobualkylation at the N9 position, the nucleophilic amination at the C6 position and the Mitsunobu alkylationor nucleophilic amination at the C2 position. However, the order of thesereactions might vary in the differentprotocols.
More recently, 2,6,8-trisubstitutedpurines were synthesized from 2,6-dichloropurine bound to Rink resin atthe N9 position16. Following conven-tional aminations at the C2 and C6 positions, the C8 substitutes were thenintroduced by bromination at the C8position and a palladium (Pd)-mediatedcross-coupling reaction.
An alternative strategy to the con-struction of the diverse combinatoriallibraries is based on natural-product-like templates. These templates haverigid conformations and the potentialfor multisite functionalization. Theyare usually assembled by highly effi-cient solid-phase chemistry as reportedby Schreiber and coworkers (Fig. 2)17,18.The same group proposed the diver-sity-oriented organic synthesis concept
Figure 1. Solution- and solid-phase syntheses of combinatorial libraries based on thepurine template.
N
N N
N
N
N
R1
R3 R2
R4
R5
N
N NH
N
Cl
(Cl)F
N
N NH
N
NH
A = SNAr aminationM = Mitsunobu alkylationB = BrominationC = Cross-coupling
Cl
N
N NH
N
N
F
R1
N
N NH
N
Cl
NR4
R5
N
N N
N
NH R1
Cl
O
CF3
CF3
O
(Ref. 14)
N
N N
N
Cl
R1
Cl
(Refs 15,16)
(Refs 9,10)
(Refs 9−11)(Refs 12,13)
(Ref. 14)
B & C
R6
A
MA
A
MM
MA
M
A
M
A
A
Drug Discovery Today
A
Figure 2. Combinatorial synthesis based on a synthetic polycyclic template17,18.Abbreviations: DIPEA, N,N,diisopropylethylamine; PyBOP, benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate.
Nucleophilic addition
HO
O
OH
O
H2N+
PyBOPDIPEA HO
O
NH
O
HO2C N+
R
O−
O
O
N
O
O RH
HH
HN
O
Electrophilic
capping
Electrophilic capping Nucleophilic
addition
Electrophiliccapping
Reductive cleavage
Electrophilic
capping
Various substituents
Various scaffoldsDrug Discovery Today
and demonstrated the importance of novel and structurallycomplex templates for generating the small-molecule libraries that are useful for exploiting chemical genomics19.
Versatile precursor-based approachThe use of highly versatile polymer-bound precursors forthe rapid generation of multiple scaffolds became an effec-tive method for quick access to diversity combinatorial libraries. These polymer-bound building blocks are usually
readily prepared from commerciallyavailable starting material, and containmultiple functional group(s) and/or reactive sites suitable for exploringstructure diversification. Unlike thetemplate-based approach, these pre-cursors undergo higher degrees ofstructure variations through a series ofchemical reactions and proliferatestructurally diverse and biologically interesting heterocyclic scaffolds.
These polymer-bound versatile pre-cursors were often developed based onclassic organic synthesis. For example,in addition to its utility in reductivealkylation, the imine moiety has beenwidely used in the formation of diversenitrogen-containing heterocyclic rings
through cycloadditions, condensation reactions and othernucleophilic additions. Several laboratories then adaptedthese conventional transformations to solid-phase synthe-sis using resin-immobilized imines via the condensation oftethered amino acids with aldehydes, generating 4-thiazol-idinone, β-lactam, pyrrolidine and polycyclic scaffolds(Fig. 3)20–23.
Armstrong24 proposed that a multiple core structure library (MCSL) generated from a common precursor
1290
DDT Vol. 6, No. 24 December 2001reviews research focus
www.drugdiscoverytoday.com
Figure 3. Resin-immobilized imines as precursors for rapid generation of multipleheterocyclic scaffolds.
X
O
R1
N R2
X
O
R1
N S
O
R2
R3
X
O
R1
N
O R3
R2X
O
R1
NH
R3
R2
X
O
N
HNR2
R3
Pg
(Ref. 21)
(Ref. 20)
(Ref. 22)
(Ref. 23)
Drug Discovery Today
Figure 4. Armstrong’s solid- and solution-phase strategies for the rapid generation of Multiple Core Structure Libraries (MCSL)24,25.
XBu3Sn
O
O
O
+
O
O
R
O
OH
O
OH
OAc
HO
O
O
HN
R
HO
N
O
O
HO
R1
R2
O
Ar
O
OHO
R1 N
O
R2
R3 HN
O
NH
N
O
R3
O
R2
R
O
HO
RORO
N
O
R2R1
NR1
R5 R6
R3
R2
R1 N
O
R2
R3
OH
O
Solid-phase Solution-phase
Drug Discovery Today
O
1291
DDT Vol. 6, No. 24 December 2001 reviewsresearch focus
www.drugdiscoverytoday.com
possesses a higher degree of diversitybecause of the structure variations notonly from the functionalities but alsofrom the orientation of the display. Asingle-core structure-based library gen-erates different compounds by chang-ing only the functionalities that aredisplayed. Squaric acid was identifiedas a versatile precursor and then at-tached to a solid support via an arylether linkage. Transformations involv-ing the polymer-bound squarates gavea variety of fused aromatic and hetero-aromatic scaffolds as shown in Fig. 4.
The same research group also applieda similar strategy to solution-phasecombinatorial synthesis. By using a ‘universal isocyanide’, 1-isocyano-cyclohexene, in the Ugi reaction, theproduct cyclohexenamides can serve as a powerful precursor to a variety of scaffolds25. An oxazolinium-5-one(münchnone) was proposed as an active intermediate that reacts withmany nucleophiles to yield the productsillustrated in Fig. 4.
Jung reported a method for the rapid expansion of ascaffold collection based on polymer-bound 3-hydroxy-2-methylidenepropionic acid26, which was prepared via theBaylis–Hillman reaction of chlorotrityl-resin-bound acrylicester with aldehydes. The presence of two functionalgroups of the precursor enabled a wide range of post-mod-ifications, such as the Michael addition, 1,3-dipolar cy-cloaddition, dehydration and electronic capping resultingin an array of interesting scaffolds (Fig. 5).
During the past several years, many laboratories inde-pendently reported the formation of various heterocyclicscaffolds using resin-immobilized 4-fluoro-3-nitrobenzoicacid. A common synthetic strategy adapted in the synthe-ses is illustrated in Fig. 6 (Refs 27–36). The first step is thedisplacement of fluoride at position 4 by various nucleo-philes, such as amines and thiols. Subsequent reductionsof the nitro-intermediates followed by various cyclizationprotocols led to different heterocyclic structures, such asbenzimidazolone, benzimidazole, benzopiperazinone, ben-zodiazepine, benzothiazepinone and tetrahydroquinoxa-linedione. A representative set of scaffolds derived fromthis building block is shown in Fig. 6.
Recently, our laboratories and others reported a similarapproach to constructing biologically important heterocyclesusing polymer-bound 4-(bromomethyl)-3-nitrobenzoate and
the corresponding amides (Fig. 7)37–39. The building blockundergoes nucleophilic displacement followed by reductionand cyclocondensation reactions to afford 3,4-dihydro-quinazolines37, benzodiazepin-2-one38, tetrahydroquina-zolinone39 and many other heterocyclic scaffolds (Fig. 7)(Zhang, J. et al., unpublished).
The ‘libraries from libraries’ conceptProposed by Houghten in 1994 (Ref. 40), the ‘libraries fromlibraries’ concept has been widely practiced in combina-torial synthesis. The central feature of the approach is theconversion of libraries into new libraries while the com-pounds remain attached to the solid support. The secondgeneration of libraries produced by this process shouldhave markedly different physical, chemical and biologicalproperties compared with the libraries from which theywere derived. Houghten demonstrated the concept by con-verting a peptide library into a permethylated one in whichthe typical –CONH– peptidic amide bond was modified byN-methylation40.
The same laboratory has extended this approach to theconstruction of small organic compound libraries. The ex-isting resin-bound peptide libraries have been successfullymodified by reduction of amide bonds followed by a seriesof further chemical manipulations to afford the secondgeneration of libraries. The linear dipeptide libraries were
Figure 5. Polymer-bound 3-hydroxy-2-methylidenepropionic acids for synthesis ofMultiple Core Structure Libraries (MCSL)26.
O
ORCHO
O
O
R1
OH
O
O
O
R1
O
O
NR7
R6
O
O
R1
OH
O
O
R1
OH
NH
R5
O
O
R1
NH
R5
O
R1
OR2
O
O
O
R1
NN
R3
O
R4
O
O
R1
NN
R3
O
R4
OH
Michael additionand further modification
Dehydrationor electrophiliccapping
Drug Discovery Today
1292
DDT Vol. 6, No. 24 December 2001reviews research focus
www.drugdiscoverytoday.com
used for the generation of small hetero-cyclic compound libraries, such as cyclicureas, thioureas, bicyclic guanidines,imidazol-pyrido-indoles, hydantoinsand thiohydantoins (Fig. 8)41–45.
Based on the same concept, a solid-phase synthesis of a piperazine libraryfrom the corresponding diketopiper-azine library has been recently demon-strated (Fig. 9a)46. The reduction of thediketopiperazines by a BH3–THF com-plex on solid support was performed inAres™ reactors on automated synthe-sizers (Advanced ChemTech, Louisville,KY, USA). A similar approach was un-dertaken to generate a highly diversifiedpiperazinone library. In this synthesis,the Ugi four-component condensationreaction was carried out on various α-amino acid Wang resins under standardconditions. An array of resin-bound
Figure 6. Polymer-bound 4-fluoro-3-nitrobenzoic acid as a versatile precursor for rapid generation of multiple heterocyclic scaffolds.
H2N
O
N
NS
R1
R2
NH
O
N
N
R3
O
R2
R4
R1
X
O
N
NR2
R1
HO
N
NO
R1
R2O
XNO2
F
O
NH
O
N
N
R2
O
R1
R3
O
X
O
N
N
R2
R3
O
R1
X
O
N
N
R1
O
ONu
H2N
O
N
NNH
R1
R2
X
O
S
N
R2
O
NHR1
Nucleophilic displacement
Reduction
Heterocyclicring formation
(Ref. 28)
(Ref. 29)
(Ref. 30)
(Refs 31,32)(Ref. 33)
(Ref. 34)
(Ref. 35)
(Ref. 36)
(Ref. 27)
Drug Discovery Today
Figure 7. Polymer-bound 4-(bromomethyl)-3-nitrobenzoic acids as a versatile precursorfor rapid generation of multiple heterocyclic scaffolds.
XNO2
O
Br
HX
O
NR1
OHN
HX
O
N
NO
R1
R2
R3
O
N
N
R1
R2
HX
Nucleophilic displacement
Reduction
Heterocyclicring formation
(Ref. 38)
(Ref. 37)
(Ref. 39) Drug Discovery Today
1293
DDT Vol. 6, No. 24 December 2001 reviewsresearch focus
www.drugdiscoverytoday.com
Ugi-products were then subjected tothe reduction by using BH3–THF at65°C for 6 h. The piperazinones werereleased via intramolecular cyclizationin the presence of 5% HOAc indichloromethane (Fig. 9b)47. The Ugireduction–cyclization strategy offers a practical extension of the repertoire of Ugi-chemistry in combinatorial synthesis.
ConclusionsThe evolution of combinatorial chem-istry has provided access to greatly ex-panded chemical collections useful forlead identification in pharmaceuticalcompanies. Several new chemical enti-ties generated from combinatorial li-braries are currently being evaluated inthe clinic for the treatment of varioushuman diseases48–50. The current trendto explore chemical diversity has shiftedfrom merely increasing the number of new compounds synthesized, gener-ating huge libraries and exploring relatively simple reactions to creating biologically relevant and information-rich combinatorial libraries in a muchmore defined and rational fashion.
Although the pharmaceutical indus-tries still continue to mainly adapt theparallel synthesis technologies for thegeneration of combinatorial libraries,the mix-and-split method devised withingenious encoding methods, such asradiofrequency, has also demonstratedgreat value. Recently, several new tech-niques, such as string synthesis51 and Euclidean shape-en-coded synthesis52, were reported to combine the high effi-ciency of the split synthesis with the advantage of theparallel method. However, putting them into real practicein pharmaceutical laboratories remains to be seen.
Developing new concepts to create novel and biologi-cally relevant scaffolds and engineering efficient strategiesto accelerate the syntheses of combinatorial libraries areimportant in the discovery of lead molecules against vari-ous new targets validated from genomics and proteomicsresearch. The combination of combinatorial chemistry, rational drug design and classic medicinal chemistryoptimization techniques is the key to delivering high-quality drug candidates in the most cost-effective manner.
Integration of innovative chemistry technologies andstate-of-the-art automation is equally important to achievethese goals.
References1 Gordon, E.M. (1998) Strategies in the design and synthesis of chemical
libraries. In Combinatorial Chemistry and Molecular Diversity in DrugDiscovery (Gordon, E.M. and Kerwin, J.F. Jr, eds), pp. 17–38
2 Guillier, F. et al. (2000) Linkers and cleavage strategies in solid-phaseorganic synthesis and combinatorial chemistry. Chem. Rev. 100,2091–2157
3 Weller, H.N. (1999) Purification of combinatorial libraries. In AnnualReports in Combinatorial Chemistry and Moleculer Diversity (Vol. 2) (Pavia, M.R. and Moos, W.H., eds), pp. 27–32
4 Böhm, H-J. et al. (2000) Structure-based library design: molecularmodelling merges with combinatorial chemistry. Curr. Opin. Chem. Biol.4, 283–286
Figure 8. Houghten’s ‘libraries from libraries’ approaches to rapid generation of multiplelinear and heterocyclic-based libraries.
NH
O
R1
HN
O
NH2
R2
H2N
O
R1
N
HNX
O
R2
H2N
R1
HN
NH2
R2
N
N
N
R2
R3
R1
H
+
HN
R1
N
R3
N
R2
X
R4
X = O, S
X = O, S
NH
N
N
R3
R2
ONH2
R(Ref. 44)
(Ref. 46)
(Ref. 45)
(Ref. 42)
(Ref. 43)
Drug Discovery Today
Figure 9. (a) Solid-phase synthesis of piperazine derivatives from the correspondingdiketopiperazine library47. (b) Solid-phase synthesis of piperazinone derivatives based onthe Ugi reduction–cyclization strategy48.
X L
O
R1
R2
O
R3
N
N
O
R1
N
R2 O
R3
NH
OR4
O
BH3−THF
N
N
R4
R3
O
R1
R2
N
R1
R2
R3
N
1 BH3−THF65˚C, 4−6 h
2 Cleavage
(a)
(b)
65˚C, 4−6 h
Cleavage
Drug Discovery Today
5 Evans, B.E. et al. (1988) Methods for drug discovery: development ofpotent, selective, orally effective cholecystokinin antagonists. J. Med.Chem. 31, 2235–2246
6 Patchett, A.A. et al. (2000) Privileged structures – an update. In Annual Report in Medicinal Chemistry (Vol. 35) (Doherty, A.M., ed.), pp. 289–298, Academic Press
7 Fujii, T. et al. (1999) The 11 positional isomers of Nx, Ny-dimethyladenine: their chemistry, physicochemical properties, andbiological activities. Heterocycles 51, 393–454
8 Sielecki, T.M. et al. (2000) Cyclin-dependent kinase inhibitors: usefultargets in cell cycle regulation. J. Med. Chem. 43, 1–18
9 Gray, N.S. et al. (1998) Exploiting chemical libraries, structure, andgenomics in the search for kinase inhibitors. Science 281, 533–538
10 Chang, Y-T. et al. (1999) Synthesis and application of functionallydiverse 2,6,9-trisubstituted purine libraries as CDK inhibitors. Chem.Biol. 6, 361–375
11 Fiorini, M.T. (1998) Solution-phase synthesis of 2,6,9-trisubstitutedpurines. Tetrahedron Lett. 39, 1827–1830
12 Gray, N.S. et al. (1997) Combinatorial synthesis of 2,9-substitutedpurines. Tetrahedron Lett. 38, 1161–1164
13 Dorff, P.H. (2001) Novel solid-phase preparation of 2,6,9-trisubstitutedpurines for combinatorial library generation. Tetrahedron Lett. 42,2771–2773
14 Norman, T.C. et al. (1996) A structure-based library approach to kinaseinhibitors. J. Am. Chem. Soc. 118, 7430–7431
15 Nugiel, D.A. et al. (1997) Facile preparation of 2,6-disubstituted purinesusing solid-phase chemistry. J. Org. Chem. 62, 201–203
16 Brill, W.K-D. et al. (2001) Solid-phase synthesis of 2,6,8-trisubstitutedpurines. Tetrahedron Lett. 42, 6515–6518
17 Tan, D.S. et al. (1998) Stereoselective synthesis of over two millioncompounds having structural features both reminiscent of naturalproducts and compatible with miniaturized cell-based assays. J. Am.Chem. Soc. 120, 8565–8566
18 Tan, D.S. et al. (1999) Synthesis and preliminary evaluation of a libraryof polycyclic small molecules for use in chemical genetic assays. J. Am.Chem. Soc. 121, 9073–9087
19 Schreiber, S.L. et al. (2000) Target-oriented and diversity-orientedorganic synthesis in drug discovery. Science 287, 1964–1969
20 Holmes, C.P. et al. (1995) Strategies for combinatorial organic synthesis:solution and polymer-supported synthesis of 4-thiazolidinones and 4-metathiazanones derived from amino acids. J. Org. Chem. 60,7328–7333
21 Ruhland, B. et al. (1996) Solid-supported combinatorial synthesis ofstructurally diverse β-lactams. J. Am. Chem. Soc. 118, 253–254
22 Murphy, M.M. et al. (1995) Combinatorial organic synthesis of highlyfunctionalized pyrrolidines: identification of a potent angiotensinconverting enzyme inhibitor from a mercaptoacyl proline library. J. Am. Chem. Soc. 117, 7029–7030
23 Peng, G. et al. (1999) Stereoselective solid-phase synthesis of a triazatricyclic ring system: a new chemotype for lead discovery. J. Org. Chem.64, 8342–8349
24 Keating, T.A. and Armstrong, R.W. (1997) Postcondensationmodifications of Ugi four-component condensation products: 1-isocyanocyclohexene as a convertible isocyanide. Mechanism ofconversion, synthesis of diverse structures, and demonstration of resincapture. J. Am. Chem. Soc. 119, 7607–7608
25 Tempest, P.A. and Armstrong, R.W. (1996) Cyclobutenedionederivatives on solid support: toward multiple core structure libraries. J. Am. Chem. Soc. 118, 2574–2583
26 Richter, H. et al. (1999) Polymer bound 3-hydroxy-2-methylidenepropionic acids. A template for multiple core structurelibraries. J. Org. Chem. 64, 1362–1365
27 Wei, G.P. and Phillips, G.B. (1998) Solid-phase synthesis ofbenzimidazolones. Tetrahedron Lett. 39, 179–182
28 Lee, J. et al. (1998) Solid-phase synthesis of 1-alkyl-2-alkylthio-5-carbamoylbenzimidazoles. Tetrahedron Lett. 39, 201–204
29 Morales, G.A. and Dorbett, J.W. et al. (1998) Solid-phase synthesis ofbenzopiperazinones. J. Org. Chem. 63, 1172–1177
30 Mayer, J.P. et al. (1998) Solid-phase synthesis of benzimidazoles.Tetrahedron Lett. 39, 6655–6658
31 Schwarz, M.K. et al. (1998) Solid-phase synthesis of 1,5-benzodiazepin-2-ones. Tetrahedron Lett. 39, 8397–8400
32 Lee, J. et al. (1999) Solid-phase synthesis of 3,4,5-substituted 1,5-benzodiazepin-2-ones. J. Org. Chem. 64, 3060–3065
33 Zaragoza, F. et al. (1999) Solid-phase synthesis of substituted 4-acyl-1,2,3,4-tetrahydroquinoxalin-2-ones. J. Org. Chem. 64, 2555–2557
34 Schwarz, M.K. et al. (1999) Solid-phase synthesis of 3,5-disubstituted2,3-dihydro-1,5-benzothiazepine-4(5H)-ones. J. Org. Chem. 64,2219–2231
35 Smith, J.M. et al. (1999) Necklace-coded polymer-supportedcombinatorial synthesis of 2-arylaminobenzimidazoles. J. Comb. Chem.1, 368–370
36 Nefzi, A. et al. (2000) Solid-phase synthesis of branched thiohydantoinbenzimidazolinethiones and branched thiohydantointetrahydroquinoxalinediones. Tetrahedron Lett. 41, 2283–2287
37 Zhang, J. et al. (2001) Solid-phase synthesis of 3,4-dihydroquinazolinederivatives. Tetrahedron Lett. 42, 8405–8408
38 Zhang, J. et al. (2001) Solid-phase synthesis of diverse 1,4-benzodiazepin-1,4-diones. American Chemical Society 221st NationalMeeting, 1–5 April 2001, San Diego, CA, USA (Abstract ORGN 0656)
39 Sun, Q. et al. (2001) Solid-phase synthesis of 3,4-dihydro-2(1H)-quinazolines and 3,4-dihydro-1H-quinazolin-2-thiones. TetrahedronLett. 42, 4119–4121
40 Ostresh, J.M. et al. (1994) ‘Libraries from libraries’: chemicaltransformation of combinatorial libraries to extend the range andrepertoire of chemical diversity. Proc. Natl. Acad. Sci. U. S. A. 91,11138–11142
41 Ostresh, J.M. et al. (1998) Solid-phase synthesis of trisubstituted bicyclicguanidines via cyclization of reduced N-acylated dipeptides. J. Org.Chem. 63, 8622–8623
42 Nafzi, A. et al. (1998) Combinatorial chemistry: from peptides andpeptidomimetics to small organic and heterocyclic compounds. Bioorg.Med. Chem. Lett. 8, 2273–2278
43 Nefzi, A. et al. (1999) Parallel solid-phase synthesis of tetrasubstituteddiethylenetriamines via selective amide alkylation and exhaustivereduction of N-acylated dipeptides. Tetrahedron 55, 335–344
44 Nefzi, A. et al. (1999) Parallel solid-phase synthesis of tetrasubstituteddiethylenetriamines via selective amide alkylation and exhaustivereduction of N-acylated dipeptides. Tetrahedron 55, 335–344
45 Nefzi, A. et al. (1997) Solid-phase synthesis of heterocyclic compoundsfrom linear peptides: cyclic ureas and thioureas. Tetrahedron Lett. 38,931–934
46 Fernandez, M. et al. (2001) Solid-phase synthesis of piperazinederivatives on ACT high-pressure reaction blocks, Ares reactors.American Chemical Society 221st National Meeting, 1–5 April 2001, San Diego, CA, USA (Abstract ORGN 0134)
47 Fernandez, M. et al. (2001) Solid-phase synthesis of piperazinonederivatives based on the Ugi reduction–cyclization strategy. AmericanChemical Society 221st National Meeting, 1–5 April 2001, San Diego, CA,USA (Abstract ORGN 0657)
48 Bunin, B.A. et al. (1999) Application of combinatorial and parallelsynthesis to medicinal chemistry. In Annual Report in MedicinalChemistry (Vol. 34) (Doherty, A.M., ed.), pp. 267–286, Academic Press
49 Golebiowski, A. et al. (2001) Lead compounds discovered from libraries.Curr. Opin. Chem. Biol. 5, 273–284
50 Dolle, R.E. (2000) Comprehensive survey of combinatorial librarysynthesis: 1999. J. Comb. Chem. 2, 383–433
51 Furka, A. et al. (2000) String synthesis. A spatially addressable splitprocedure. J. Comb. Chem. 2, 220–223
52 Vaino, A.R. and Janda, K.D. (2000) Euclidean shape-encodedcombinatorial chemical libraries. Proc. Natl. Acad. Sci. U. S. A. 97,7692–7696
1294
DDT Vol. 6, No. 24 December 2001reviews research focus
www.drugdiscoverytoday.com